The VEGFA -1154G/A polymorphism is associated with reduced risk of rheumatoid arthritis but not with systemic lupus erythematosus in Mexican women

The Journal of Gene Medicine
J Ramírez BelloSilvia Jiménez-Morales

Abstract

Levels of circulating vascular endothelial growth factor (VEGF) (a potent endothelial-cell-specific angiogenic factor) have been correlated with disease activity in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In addition, several single nucleotide polymorphisms (SNPs), including the VEGFA -2578C/A, have been associated with RA in some populations. By contrast, the role of different VEGFA SNPs in the susceptibility to SLE has received little attention. Thus, the present study aimed to determine whether the VEGFA -2578C/A, -1154G/A and -634G/C polymorphisms confer risk or were associated with reduced risk of RA or SLE in a Mexican population. The present study included 903 women from Mexico: 405 were patients with RA, 282 had SLE and 216 were healthy individuals. The genotypes were obtained with TaqMan probes. The data obtained in the present study suggest that the VEGFA -2578C/A and -634G/C polymorphisms are not risk factors for RA or SLE; however, VEGFA -1154G/A was associated with reduced risk in women with RA (odds ratio = 0.6, pc  = 0.0051) but not with SLE (odds ratio = 0.7, pc  = 0.13). The present study is the first to document an association between VEGFA -1154G/A and reduced risk in w...Continue Reading

References

May 16, 2003·Vascular Pharmacology·D O Bates, S J Harper
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Nov 16, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Michael I KoukourakisEfthimios Siviridis
Apr 15, 2006·BMJ : British Medical Journal·David P D'Cruz
Jan 22, 2008·The New England Journal of Medicine·Geoffrey HomTimothy W Behrens
Jan 22, 2008·Nature Genetics·UNKNOWN International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN)Jennifer A Kelly
Apr 17, 2010·Nature Reviews. Genetics·Noah A RosenbergMichael Boehnke
Sep 28, 2010·Lancet·David L ScottTom W J Huizinga
Nov 19, 2010·Nature Protocols·Carl A AndersonKrina T Zondervan
Jan 5, 2011·The Journal of Rheumatology. Supplement·Ingris Peláez-BallestasUNKNOWN Grupo de Estudio Epidemiológico de Enfermedades Músculo Articulares (GEEMA)
Jan 20, 2011·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Hao-zhe LvJing Lu
Jun 7, 2013·Annals of the Rheumatic Diseases·Hye-Soon LeeSang-Cheol Bae
Feb 18, 2014·Annals of the Rheumatic Diseases·L Bossini-CastilloB P C Koeleman
Dec 23, 2014·American Journal of Human Genetics·Katarzyna BrycJoanna L Mountain
Jul 23, 2015·Angiogenesis·Hatem A ElshabrawyShiva Shahrara
Jan 31, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jin-Ping YiQuan Yuan
May 15, 2016·Immunology Letters·O Beltrán RamírezJ Ramírez Bello
May 14, 2017·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Daniela Josabeth López-CanoJulian Ramírez-Bello
Jul 18, 2017·Nature Communications·Carl D LangefeldTimothy J Vyse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.